Urgent: Field Safety Notice – MSS-15-637 FA
For the Attention of:
- Customers who use BD Hypodermic Syringes listed within the “Read more” document line, not for immediate use.
- Procurement, Medical Director, Risk Manager, Head of Pharmacy, Medical Device Safety Officer
These syringes are cleared for use in general purpose fluid aspiration/injection only and the
concerns addressed in this Field Safety Notification do not relate to that cleared use.
Description of the problem:
We have received reports from US customers of decreased potency when drugs are compounded or repackaged and stored in BD Plastipak Syringes.
Because of the potential public health impact when the syringes are used in this way, we are issuing this communication to assist in identifying affected syringes. Read More